Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: Dose response

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 1 I, 1996, Pages 47-52

  Bhagat, Rajesh ^a   Swystun, Veronica A ^a   Cockcroft, Donald W ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

allergen inhalation test; methacholine inhalation test; 2 agonist tolerance

Indexed keywords

ALLERGEN; METHACHOLINE; PLACEBO; SALBUTAMOL;

ADULT; ALLERGIC REACTION; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0030027935     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70282-8     Document Type: Article

References (21)

1. Gibson GJ, Greenacre JK, Konig P, Conolly ME, Pride NB. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 1978;72:199-206.
2. Ramage L, Lipworth BJ, Ingram CG, Cree JA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Resp Med 1994;88:363-8.
3. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;1:554-7.
4. 2-agonists in asthma. N Engl J Med 1992;327:1204-8.
5. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203.
6. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
7. 2 agonist and inhaled corticosteriod on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995 (in press).
8. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
9. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-10.
10. 20: comparison of linear and logarithmic interpolation. Chest 1983;84:505-6.
11. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987;135:264-7.
12. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J ALLERGY CLIN IMMUNOL 1987;79:734-40.
13. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J ALLERGY CLIN IMMUNOL 1995;96:44-9.
14. Gauyreau GM, Watson RM, Jordana M, Cockcoft D, O'Byrne PM. The effect of regular inhaled salbutamol on allergen-induced airway responses and inflammatory cells in blood and induced sputum. Am J Respir Crit Care Med 1995;151:A39.
15. Flint KC, Leung KBP, Hudspith BN, Brostoff J, Pearce FL, Johnson NM. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. BMJ 1985;291:923-6.
16. Kraan J, Koeter GH, Mark ThWvd, Sluiter HJ, deVries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J ALLERGY CLIN IMMUNOL 1985;76:628-36.
17. Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effects of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J ALLERGY CLIN IMMUNOL 1987;79:653-9.
18. Davies RJ, Trigg CJ, Wang JH, et al. Regular inhaled salbutamol may exacerbate bronchial inflammation in patients with mild asthma. Thorax 1993;48:1060.
19. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonist and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
20. Suissa S, Ernst P, Boivin J-F, et al. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med 1994;149:604-10.
21. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.